Shares of Brenntag AG (OTCMKTS:BNTGY – Get Free Report) have received a consensus recommendation of “Reduce” from the nine brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $12.80.
BNTGY has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft cut shares of Brenntag from a “buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Jefferies Financial Group raised shares of Brenntag from a “moderate sell” rating to a “hold” rating in a research report on Wednesday, May 20th. Morgan Stanley reiterated an “underweight” rating on shares of Brenntag in a research note on Friday, May 15th. Finally, UBS Group upgraded Brenntag from a “sell” rating to a “neutral” rating in a research note on Thursday, April 30th.
Get Our Latest Stock Report on BNTGY
Brenntag Price Performance
Brenntag (OTCMKTS:BNTGY – Get Free Report) last posted its earnings results on Wednesday, May 13th. The company reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.02). Brenntag had a net margin of 1.55% and a return on equity of 5.28%. The company had revenue of $4.29 billion during the quarter, compared to analyst estimates of $4.33 billion. On average, research analysts anticipate that Brenntag will post 0.8 earnings per share for the current year.
Brenntag Company Profile
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
Featured Stories
- Five stocks we like better than Brenntag
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.
